Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$7,259,986
+$289,047 QoQ
Shares Held
28,586
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,320
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $61,483,180 across 10 Drug Manufacturers - General names. JNJ ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,397 | $29,262,496 | |
| 2 | ABBV |
AbbVie Inc.
|
45,639 | $11,484,597 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
28,586 | $7,259,986 | |
| 4 | AMGN |
Amgen Inc
|
16,862 | $6,106,067 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,615 | $2,135,027 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
25,296 | $1,457,555 | |
| 7 | NVO |
Novo Nordisk A S
|
25,368 | $1,216,141 | |
| 8 | PFE |
Pfizer Inc
|
38,365 | $923,829 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,259,986 | 28,586 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $6,970,939 | 28,518 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $6,966,557 | 33,663 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,213,980 | 33,513 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,086,575 | 33,300 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,960,289 | 35,940 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,376,248 | 37,175 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,890,718 | 36,349 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $4,338,613 | 29,684 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,909,742 | 31,037 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $5,171,635 | 32,995 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,281,171 | 33,908 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,694,219 | 34,402 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,465,300 | 35,260 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,662,354 | 37,715 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,365,485 | 38,966 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $6,699,759 | 37,743 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,583,385 | 37,146 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $6,416,493 | 37,508 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,814,654 | 42,196 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,010,840 | 42,557 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $7,011,335 | 42,661 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,430,861 | 40,862 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,348,094 | 42,639 | Shares | Defined | 2020-12-14 | |
| 2020-06-30 | $6,198,548 | 44,077 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,382,621 | 48,674 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||